Skip to main content
Top
Published in: Supportive Care in Cancer 5/2020

01-05-2020 | Obesity | Original Article

Sleep, quality of life, and depression in endometrial cancer survivors with obesity seeking weight loss

Authors: Nora L. Nock, Anastasia Dimitropoulos, Kristine M. Zanotti, Steven Waggoner, Christa Nagel, Mladen Golubic, Chad M. Michener, John P. Kirwan, Jay Alberts

Published in: Supportive Care in Cancer | Issue 5/2020

Login to get access

Abstract

Purpose

Incidence and mortality rates of uterine cancer are increasing and, obesity, which is also rising, has been associated with uterine cancer development and mortality. A recent study found that poor sleep quality is common among endometrial cancer survivors and those with obesity had more sleep disturbances than those having normal weight. However, it is unclear if higher levels of obesity (Class III, BMI ≥ 40 kg/m2), which are rising rapidly, are differentially associated with sleep as well as depression and quality of life in endometrial cancer survivors.

Methods

We evaluated sleep, depression, and quality of life in 100 Stage I endometrial cancer survivors with obesity seeking weight loss enrolled in a lifestyle intervention (NCT01870947) at baseline.

Results

The average age was 60 years and mean BMI was 42.1 kg/m2 with 58% having a BMI ≥ 40 kg/m2. Most survivors (72.3%) had poor sleep quality and most (71.2%) reported sleeping < 7 h/night. Survivors with class III compared with class I obesity had significantly more sleep disturbances and daytime dysfunction; and, those with poor sleep had higher depression and lower quality of life. Survivors with a BMI ≥ 50 kg/m2 (~ 25%) had the highest levels of depression and lowest physical and emotional well-being.

Conclusions

Our results reveal that endometrial cancer survivors with class III compared with class I obesity have poorer sleep quality, higher depression, and lower quality of life. Given the rising rates of obesity and uterine cancer mortality, interventions to combat both obesity and poor sleep are needed.
Literature
2.
go back to reference American Cancer Society 2016 Cancer treatment and survivorship facts and figures. Ref Type: Report American Cancer Society 2016 Cancer treatment and survivorship facts and figures. Ref Type: Report
3.
go back to reference Duong LM, Wilson RJ, Ajani UA, Singh SD, Eheman CR (2011) Trends in endometrial cancer incidence rates in the United States, 1999–2006. J. Womens Health (Larchmt.) 20:1157–1163CrossRef Duong LM, Wilson RJ, Ajani UA, Singh SD, Eheman CR (2011) Trends in endometrial cancer incidence rates in the United States, 1999–2006. J. Womens Health (Larchmt.) 20:1157–1163CrossRef
4.
go back to reference Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66:271–289PubMedCrossRef Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66:271–289PubMedCrossRef
5.
go back to reference Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578PubMedCrossRef Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578PubMedCrossRef
6.
go back to reference Secord AA, Hasselblad V, von Gruenigen VE, Gehrig PA, Modesitt SC, Bae-Jump V, Havrilesky LJ (2016) Body mass index and mortality in endometrial cancer: a systematic review and meta-analysis. Gynecol.Oncol. 140:184–190PubMedCrossRef Secord AA, Hasselblad V, von Gruenigen VE, Gehrig PA, Modesitt SC, Bae-Jump V, Havrilesky LJ (2016) Body mass index and mortality in endometrial cancer: a systematic review and meta-analysis. Gynecol.Oncol. 140:184–190PubMedCrossRef
7.
go back to reference Chang SC, Lacey JV Jr, Brinton LA, Hartge P, Adams K, Mouw T, Carroll L, Hollenbeck A, Schatzkin A, Leitzmann MF (2007) Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP Diet and Health Study. Cancer Epidemiol. Biomarkers Prev. 16:723–730PubMedCrossRef Chang SC, Lacey JV Jr, Brinton LA, Hartge P, Adams K, Mouw T, Carroll L, Hollenbeck A, Schatzkin A, Leitzmann MF (2007) Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP Diet and Health Study. Cancer Epidemiol. Biomarkers Prev. 16:723–730PubMedCrossRef
8.
go back to reference Park SL, Goodman MT, Zhang ZF, Kolonel LN, Henderson BE, Setiawan VW (2010) Body size, adult BMI gain and endometrial cancer risk: the multiethnic cohort. Int.J.Cancer 126:490–499PubMedPubMedCentralCrossRef Park SL, Goodman MT, Zhang ZF, Kolonel LN, Henderson BE, Setiawan VW (2010) Body size, adult BMI gain and endometrial cancer risk: the multiethnic cohort. Int.J.Cancer 126:490–499PubMedPubMedCentralCrossRef
9.
go back to reference Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335:1134PubMedPubMedCentralCrossRef Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335:1134PubMedPubMedCentralCrossRef
10.
go back to reference Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638PubMedCrossRef Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638PubMedCrossRef
11.
go back to reference Felix AS, Bower JK, Pfeiffer RM, Raman SV, Cohn DE, Sherman ME (2017) High cardiovascular disease mortality after endometrial cancer diagnosis: results from the Surveillance, Epidemiology, and End Results (SEER) database. Int J Cancer 140:555–564PubMedCrossRef Felix AS, Bower JK, Pfeiffer RM, Raman SV, Cohn DE, Sherman ME (2017) High cardiovascular disease mortality after endometrial cancer diagnosis: results from the Surveillance, Epidemiology, and End Results (SEER) database. Int J Cancer 140:555–564PubMedCrossRef
12.
go back to reference Ward KK, Shah NR, Saenz CC, McHale MT, Alvarez EA, Plaxe SC (2012) Cardiovascular disease is the leading cause of death among endometrial cancer patients. Gynecol Oncol 126:176–179PubMedCrossRef Ward KK, Shah NR, Saenz CC, McHale MT, Alvarez EA, Plaxe SC (2012) Cardiovascular disease is the leading cause of death among endometrial cancer patients. Gynecol Oncol 126:176–179PubMedCrossRef
13.
go back to reference Sturm R, Hattori A (2013) Morbid obesity rates continue to rise rapidly in the United States. Int J Obes.(Lond) 37:889–891CrossRef Sturm R, Hattori A (2013) Morbid obesity rates continue to rise rapidly in the United States. Int J Obes.(Lond) 37:889–891CrossRef
14.
go back to reference Morbidity and Mortality Weekly Report 2010 (59(17);527). 2010. Center for Disease Control and Prevention. Ref Type: Online Source Morbidity and Mortality Weekly Report 2010 (59(17);527). 2010. Center for Disease Control and Prevention. Ref Type: Online Source
15.
go back to reference Akinnusi ME, Saliba R, Porhomayon J, El-Solh AA (2012) Sleep disorders in morbid obesity. Eur J Intern Med 23:219–226PubMedCrossRef Akinnusi ME, Saliba R, Porhomayon J, El-Solh AA (2012) Sleep disorders in morbid obesity. Eur J Intern Med 23:219–226PubMedCrossRef
16.
go back to reference Vgontzas AN, Tan TL, Bixler EO, Martin LF, Shubert D, Kales A (1994) Sleep apnea and sleep disruption in obese patients. Arch Intern Med 154:1705–1711PubMedCrossRef Vgontzas AN, Tan TL, Bixler EO, Martin LF, Shubert D, Kales A (1994) Sleep apnea and sleep disruption in obese patients. Arch Intern Med 154:1705–1711PubMedCrossRef
17.
go back to reference Pender JR, Pories WJ (2005) Epidemiology of obesity in the United States. Gastroenterol Clin North Am 34:1–7PubMedCrossRef Pender JR, Pories WJ (2005) Epidemiology of obesity in the United States. Gastroenterol Clin North Am 34:1–7PubMedCrossRef
18.
go back to reference Petry NM, Barry D, Pietrzak RH, Wagner JA (2008) Overweight and obesity are associated with psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychosom Med 70:288–297PubMedCrossRef Petry NM, Barry D, Pietrzak RH, Wagner JA (2008) Overweight and obesity are associated with psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychosom Med 70:288–297PubMedCrossRef
19.
go back to reference Li N, Otomaru T, Taniguchi H (2017) Sleep quality in long-term survivors of head and neck cancer: preliminary findings. Support Care Cancer 25:3741–3748PubMedCrossRef Li N, Otomaru T, Taniguchi H (2017) Sleep quality in long-term survivors of head and neck cancer: preliminary findings. Support Care Cancer 25:3741–3748PubMedCrossRef
20.
go back to reference Schmidt ME, Wiskemann J, Steindorf K (2018) Quality of life, problems, and needs of disease-free breast cancer survivors 5 years after diagnosis. Qual Life Res 27:2077–2086PubMedCrossRef Schmidt ME, Wiskemann J, Steindorf K (2018) Quality of life, problems, and needs of disease-free breast cancer survivors 5 years after diagnosis. Qual Life Res 27:2077–2086PubMedCrossRef
21.
go back to reference Armbruster SD, Song J, Gatus L, Lu KH, Basen-Engquist KM (2018) Endometrial cancer survivors’ sleep patterns before and after a physical activity intervention: a retrospective cohort analysis. Gynecol Oncol 149:133–139PubMedPubMedCentralCrossRef Armbruster SD, Song J, Gatus L, Lu KH, Basen-Engquist KM (2018) Endometrial cancer survivors’ sleep patterns before and after a physical activity intervention: a retrospective cohort analysis. Gynecol Oncol 149:133–139PubMedPubMedCentralCrossRef
22.
go back to reference Nock, N. L., Dimitropoulos, A., Rao, S. M., Flask, C. A., Schluchter, M., Zanotti, K.M., Rose, P.G., Kirwan, J.P., and Alberts, J. (2014) Rationale and design of REWARD (revving-up exercise for sustained weight loss by altering neurological reward and drive): a randomized trial in obese endometrial cancer survivors. Contemporary clinical trials, 39. Nock, N. L., Dimitropoulos, A., Rao, S. M., Flask, C. A., Schluchter, M., Zanotti, K.M., Rose, P.G., Kirwan, J.P., and Alberts, J. (2014) Rationale and design of REWARD (revving-up exercise for sustained weight loss by altering neurological reward and drive): a randomized trial in obese endometrial cancer survivors. Contemporary clinical trials, 39.
23.
go back to reference Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213PubMedCrossRef Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213PubMedCrossRef
24.
go back to reference Beck SL, Schwartz AL, Towsley G, Dudley W, Barsevick A (2004) Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients. J Pain Symptom Manage 27:140–148PubMedCrossRef Beck SL, Schwartz AL, Towsley G, Dudley W, Barsevick A (2004) Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients. J Pain Symptom Manage 27:140–148PubMedCrossRef
25.
go back to reference Beck AT, Steer RA, Brown GK (1996) Beck Depression Inventory. In: The Psychological Corporation. Harcourt Brace Jovanovich, San Antonio Beck AT, Steer RA, Brown GK (1996) Beck Depression Inventory. In: The Psychological Corporation. Harcourt Brace Jovanovich, San Antonio
26.
go back to reference Vodermaier A, Linden W, Siu C (2009) Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst 101:1464–1488PubMedPubMedCentralCrossRef Vodermaier A, Linden W, Siu C (2009) Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst 101:1464–1488PubMedPubMedCentralCrossRef
27.
go back to reference Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579PubMedCrossRef Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579PubMedCrossRef
28.
go back to reference Webster, K., Cella, D., and Yost, K. (2003) The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual. Life Outcomes., 1, 79. Webster, K., Cella, D., and Yost, K. (2003) The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual. Life Outcomes., 1, 79.
29.
go back to reference Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13:63–74PubMedCrossRef Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13:63–74PubMedCrossRef
30.
go back to reference World Health Organization (WHO) 2000 Ref Type: Online Source World Health Organization (WHO) 2000 Ref Type: Online Source
31.
go back to reference Holzner B, Kemmler G, Cella D, De PC, Meraner V, Kopp M, Greil R, Fleischhacker WW, Sperner-Unterweger B (2004) Normative data for functional assessment of cancer therapy--general scale and its use for the interpretation of quality of life scores in cancer survivors. Acta Oncol 43:153–160PubMedCrossRef Holzner B, Kemmler G, Cella D, De PC, Meraner V, Kopp M, Greil R, Fleischhacker WW, Sperner-Unterweger B (2004) Normative data for functional assessment of cancer therapy--general scale and its use for the interpretation of quality of life scores in cancer survivors. Acta Oncol 43:153–160PubMedCrossRef
32.
go back to reference Dobrzycka B, Terlikowski R, Kulesza-Bronczyk B, Niklinski J, Terlikowsk SJ (2017) Quality of life in long-term survivors of early stage endometrial cancer. Ann Agric Environ Med 24:513–516PubMedCrossRef Dobrzycka B, Terlikowski R, Kulesza-Bronczyk B, Niklinski J, Terlikowsk SJ (2017) Quality of life in long-term survivors of early stage endometrial cancer. Ann Agric Environ Med 24:513–516PubMedCrossRef
33.
go back to reference Becker M, Malafy T, Bossart M, Henne K, Gitsch G, Denschlag D (2011) Quality of life and sexual functioning in endometrial cancer survivors. Gynecol Oncol 121:169–173PubMedCrossRef Becker M, Malafy T, Bossart M, Henne K, Gitsch G, Denschlag D (2011) Quality of life and sexual functioning in endometrial cancer survivors. Gynecol Oncol 121:169–173PubMedCrossRef
34.
go back to reference Vaz AF, Pinto-Neto AM, Conde DM, Costa-Paiva L, Morais SS, Pedro AO, Esteves SB (2011) Quality of life and menopausal and sexual symptoms in gynecologic cancer survivors: a cohort study. Menopause 18:662–669PubMedCrossRef Vaz AF, Pinto-Neto AM, Conde DM, Costa-Paiva L, Morais SS, Pedro AO, Esteves SB (2011) Quality of life and menopausal and sexual symptoms in gynecologic cancer survivors: a cohort study. Menopause 18:662–669PubMedCrossRef
35.
go back to reference Smits A, Lopes A, Das N, Bekkers R, Galaal K (2014) The impact of BMI on quality of life in obese endometrial cancer survivors: does size matter? Gynecol Oncol 132:137–141PubMedCrossRef Smits A, Lopes A, Das N, Bekkers R, Galaal K (2014) The impact of BMI on quality of life in obese endometrial cancer survivors: does size matter? Gynecol Oncol 132:137–141PubMedCrossRef
36.
go back to reference Smits A, Lopes A, Das N, Bekkers R, Massuger L, Galaal K (2015) The effect of lifestyle interventions on the quality of life of gynaecological cancer survivors: a systematic review and meta-analysis. Gynecol Oncol 139:546–552PubMedCrossRef Smits A, Lopes A, Das N, Bekkers R, Massuger L, Galaal K (2015) The effect of lifestyle interventions on the quality of life of gynaecological cancer survivors: a systematic review and meta-analysis. Gynecol Oncol 139:546–552PubMedCrossRef
37.
go back to reference Warmenhoven F, van RE, Engels Y, Kan C, Prins J, van WC, Vissers K (2012) The Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in Dutch advanced cancer patients. Support Care Cancer 20:319–324PubMedCrossRef Warmenhoven F, van RE, Engels Y, Kan C, Prins J, van WC, Vissers K (2012) The Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in Dutch advanced cancer patients. Support Care Cancer 20:319–324PubMedCrossRef
38.
go back to reference Westin SN, Sun CC, Tung CS, Lacour RA, Meyer LA, Urbauer DL, Frumovitz MM, Lu KH, Bodurka DC (2016) Survivors of gynecologic malignancies: impact of treatment on health and well-being. J Cancer Surviv 10:261–270PubMedCrossRef Westin SN, Sun CC, Tung CS, Lacour RA, Meyer LA, Urbauer DL, Frumovitz MM, Lu KH, Bodurka DC (2016) Survivors of gynecologic malignancies: impact of treatment on health and well-being. J Cancer Surviv 10:261–270PubMedCrossRef
39.
go back to reference Westby RP, Berg CJ, Leach C (2016) Gender, race, BMI, and social support in relation to the health-related quality of life of cancer survivors: a report from the American Cancer Society’s Study of Cancer Survivors II (SCS-II). Qual Life Res 25:409–421PubMedCrossRef Westby RP, Berg CJ, Leach C (2016) Gender, race, BMI, and social support in relation to the health-related quality of life of cancer survivors: a report from the American Cancer Society’s Study of Cancer Survivors II (SCS-II). Qual Life Res 25:409–421PubMedCrossRef
40.
go back to reference Blanchard CM, Stein K, Courneya KS (2010) Body mass index, physical activity, and health-related quality of life in cancer survivors. Med.Sci.Sports Exerc 42:665–671PubMedCrossRef Blanchard CM, Stein K, Courneya KS (2010) Body mass index, physical activity, and health-related quality of life in cancer survivors. Med.Sci.Sports Exerc 42:665–671PubMedCrossRef
41.
go back to reference Baker F, Denniston M, Smith T, West MM (2005) Adult cancer survivors: how are they faring? Cancer 104:2565–2576PubMedCrossRef Baker F, Denniston M, Smith T, West MM (2005) Adult cancer survivors: how are they faring? Cancer 104:2565–2576PubMedCrossRef
42.
go back to reference Sandadi S, Frasure HE, Broderick MJ, Waggoner SE, Miller JA, von Gruenigen VE (2011) The effect of sleep disturbance on quality of life in women with ovarian cancer. Gynecol Oncol 123:351–355PubMedCrossRef Sandadi S, Frasure HE, Broderick MJ, Waggoner SE, Miller JA, von Gruenigen VE (2011) The effect of sleep disturbance on quality of life in women with ovarian cancer. Gynecol Oncol 123:351–355PubMedCrossRef
43.
go back to reference Serra, M. C., Goldberg, A. P., and Ryan, A. S. (2016) Increased depression and metabolic risk in postmenopausal breast cancer survivors. Diabetol. Metab Syndr., 8, 44. Serra, M. C., Goldberg, A. P., and Ryan, A. S. (2016) Increased depression and metabolic risk in postmenopausal breast cancer survivors. Diabetol. Metab Syndr., 8, 44.
44.
go back to reference Rigobon, A. V., Kanagasabai, T., and Taylor, V. H. (2018) Obesity moderates the complex relationships between inflammation, oxidative stress, sleep quality and depressive symptoms. BMC Obes., 5, 32. Rigobon, A. V., Kanagasabai, T., and Taylor, V. H. (2018) Obesity moderates the complex relationships between inflammation, oxidative stress, sleep quality and depressive symptoms. BMC Obes., 5, 32.
45.
go back to reference Liu Y, Wheaton AG, Chapman DP, Croft JB (2013) Sleep duration and chronic diseases among U.S. adults age 45 years and older: evidence from the 2010 Behavioral Risk Factor Surveillance System. Sleep 36:1421–1427PubMedPubMedCentralCrossRef Liu Y, Wheaton AG, Chapman DP, Croft JB (2013) Sleep duration and chronic diseases among U.S. adults age 45 years and older: evidence from the 2010 Behavioral Risk Factor Surveillance System. Sleep 36:1421–1427PubMedPubMedCentralCrossRef
46.
go back to reference Grandner, M. A., Patel, N., and Perlis, M. L. 2011 Obesity, diabetes, and exercise associated with sleep-related complaints in the American population. Z Gesundh Wiss. 19(5), 463–74. Ref Type: Journal (Full)PubMedCrossRef Grandner, M. A., Patel, N., and Perlis, M. L. 2011 Obesity, diabetes, and exercise associated with sleep-related complaints in the American population. Z Gesundh Wiss. 19(5), 463–74. Ref Type: Journal (Full)PubMedCrossRef
47.
go back to reference Ford ES, Moriarty DG, Zack MM, Mokdad AH, Chapman DP (2001) Self-reported body mass index and health-related quality of life: findings from the Behavioral Risk Factor Surveillance System. Obes. Res 9:21–31PubMedCrossRef Ford ES, Moriarty DG, Zack MM, Mokdad AH, Chapman DP (2001) Self-reported body mass index and health-related quality of life: findings from the Behavioral Risk Factor Surveillance System. Obes. Res 9:21–31PubMedCrossRef
48.
go back to reference Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL (2018) Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007-2008 to 2015-2016. JAMA 319:1723–1725PubMedPubMedCentralCrossRef Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL (2018) Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007-2008 to 2015-2016. JAMA 319:1723–1725PubMedPubMedCentralCrossRef
49.
go back to reference Thomson CA, Morrow KL, Flatt SW, Wertheim BC, Perfect MM, Ravia JJ, Sherwood NE, Karanja N, Rock CL (2012) Relationship between sleep quality and quantity and weight loss in women participating in a weight-loss intervention trial. Obesity (Silver.Spring) 20:1419–1425CrossRef Thomson CA, Morrow KL, Flatt SW, Wertheim BC, Perfect MM, Ravia JJ, Sherwood NE, Karanja N, Rock CL (2012) Relationship between sleep quality and quantity and weight loss in women participating in a weight-loss intervention trial. Obesity (Silver.Spring) 20:1419–1425CrossRef
50.
go back to reference Sawamoto, R., Nozaki, T., Furukawa, T., Tanahashi, T., Morita, C., Hata, T., Komaki, G., and Sudo, N. (2014) Higher sleep fragmentation predicts a lower magnitude of weight loss in overweight and obese women participating in a weight-loss intervention. Nutr. Diabetes, 4, e144CrossRef Sawamoto, R., Nozaki, T., Furukawa, T., Tanahashi, T., Morita, C., Hata, T., Komaki, G., and Sudo, N. (2014) Higher sleep fragmentation predicts a lower magnitude of weight loss in overweight and obese women participating in a weight-loss intervention. Nutr. Diabetes, 4, e144CrossRef
51.
go back to reference Courneya KS, Karvinen KH, Campbell KL, Pearcey RG, Dundas G, Capstick V, Tonkin KS (2005) Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors. Gynecol.Oncol 97:422–430PubMedCrossRef Courneya KS, Karvinen KH, Campbell KL, Pearcey RG, Dundas G, Capstick V, Tonkin KS (2005) Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors. Gynecol.Oncol 97:422–430PubMedCrossRef
52.
go back to reference Donnelly CM, Blaney JM, Lowe-Strong A, Rankin JP, Campbell A, McCrum-Gardner E, Gracey JH (2011) A randomised controlled trial testing the feasibility and efficacy of a physical activity behavioural change intervention in managing fatigue with gynaecological cancer survivors. Gynecol.Oncol 122:618–624PubMedCrossRef Donnelly CM, Blaney JM, Lowe-Strong A, Rankin JP, Campbell A, McCrum-Gardner E, Gracey JH (2011) A randomised controlled trial testing the feasibility and efficacy of a physical activity behavioural change intervention in managing fatigue with gynaecological cancer survivors. Gynecol.Oncol 122:618–624PubMedCrossRef
53.
go back to reference von Gruenigen, V. E., Gibbons, H. E., Kavanagh, M. B., Janata, J. W., Lerner, E., and Courneya, K. S. (2009) A randomized trial of a lifestyle intervention in obese endometrial cancer survivors: quality of life outcomes and mediators of behavior change. Health Qual. Life Outcomes., 7, 17 von Gruenigen, V. E., Gibbons, H. E., Kavanagh, M. B., Janata, J. W., Lerner, E., and Courneya, K. S. (2009) A randomized trial of a lifestyle intervention in obese endometrial cancer survivors: quality of life outcomes and mediators of behavior change. Health Qual. Life Outcomes., 7, 17
54.
go back to reference Beavis AL, Smith AJ, Fader AN (2016) Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and management. Int J Womens Health 8:151–167PubMedPubMedCentral Beavis AL, Smith AJ, Fader AN (2016) Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and management. Int J Womens Health 8:151–167PubMedPubMedCentral
55.
go back to reference Ohayon MM, Roth T (2003) Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res 37:9–15PubMedCrossRef Ohayon MM, Roth T (2003) Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res 37:9–15PubMedCrossRef
Metadata
Title
Sleep, quality of life, and depression in endometrial cancer survivors with obesity seeking weight loss
Authors
Nora L. Nock
Anastasia Dimitropoulos
Kristine M. Zanotti
Steven Waggoner
Christa Nagel
Mladen Golubic
Chad M. Michener
John P. Kirwan
Jay Alberts
Publication date
01-05-2020
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 5/2020
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-05051-1

Other articles of this Issue 5/2020

Supportive Care in Cancer 5/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine